Poster Session I - ACUTE ISCHEMIC STROKE MANAGEMENT 01.00 - ACUTE ISCHEMIC STROKE MANAGEMENT - 01.05 - NEUROINTERVENTION P083 - ESOC25-231 COMORBIDITY BURDEN AND OUTCOMES AFTER ENDOVASCULAR THROMBECTOMY FOR MEDIUM VESSEL OCCLUSIONS Emma Hall 1 , Johan Wasselius 1 , Mats Pihlsgrd 2 , Teresa Ullberg 3 , Bjrn Hansen 1 1 Diagnostic Radiology, Department of Clinical Science, Lund, Sweden, 2 Perinatal and Cardiovascular Epidemiology, Department of Clinical Science, Malm, Sweden, 3 Department of Neurology, Department of Clinical Science, Malm, Sweden Background and Aims: Patients with severe comorbidities are underrepresented in the ongoing randomized endovascular thrombectomy (EVT) trials for medium vessel occlusions (MeVOs)
Prepare the injection: Remove the cap from the needle and use the syringe to draw the appropriate amount of B12 from the vial
The honest answer is that the evidence cannot say, because no study has ever compared them directly in the same model, let alone in humans
iCare does the opposite
Urolithin A prevents focal cerebral ischemic injury via attenuating apoptosis and neuroinflammation in mice
